苏州和林微纳科技股份有限公司 证券代码：688661 证券简称：和林微纳 编号：2025-026 关于转让投资基金份额暨退出投资基金的公告 2024 年 12 月，公司收到通知，顺融进取四期完成了出资额及合伙人事项的 变更，具体内容详见公司于 2024 年 12 月 11 日在上海证券交易所网站 （www.sse.com.cn）披露的《关于认购私募投资基金份额的进展公告》（公告编 号：2024-036）。 基于公司投资战略布局和未来发展规划，经与各方充分沟通并友好协商，一 致同意公司将在顺融进取四期的全部出资份额（认缴出资额 2000 万元、实缴出 资额 600 万元）及对应的财产份额分别转让给新有限合伙人苏州敏芯微电子技术 股份有限公司、苏州安洁资本投资有限公司、王强。 2025 年 7 月 29 日，公司召开第二届董事会第十七次会议，审议通过了《关 于转让投资基金份额暨退出投资基金的议案》，同意公司转让投资基金份额并退 出投资基金的事项，本次转让完成后，公司将不再持有顺融进取四期份额。 一、交易概述 二、受让方基本情况 （一）受让方 1 1、名称：苏州敏芯微电子技术股份有限公司 2、统一社会信用代码：91 ...

Investment Rating - The report maintains an "Outperform" rating for the semiconductor testing equipment industry [1]. Core Insights - The rapid development of AI chips and HBM (High Bandwidth Memory) is driving new testing demands in the semiconductor industry, highlighting the need for improved domestic production capabilities in testing equipment [1][4]. - The domestic semiconductor testing equipment market is expected to grow significantly, with projections indicating a market size of 26.74 billion yuan by 2027, reflecting a compound annual growth rate (CAGR) of approximately 12.6% [16]. - The report emphasizes the importance of post-manufacturing testing to ensure that chips meet design specifications, with a focus on the core testing equipment: testing machines, sorting machines, and probe stations [8][14]. Summary by Sections 1. Semiconductor Post-Manufacturing Testing - Semiconductor testing is crucial across design, manufacturing, and packaging stages to ensure chip functionality meets design specifications [6][8]. - The testing equipment market is stable, with testing machines accounting for over 61.9% of the market share in 2022 [16]. 2. New Requirements from AI Chips and HBM - AI chips are experiencing rapid growth, with the global AI chip market expected to reach approximately $92 billion by 2025, growing at a CAGR of 27.7% [22]. - The complexity of AI chip designs and advanced manufacturing processes increases testing challenges, necessitating more efficient testing systems [29]. 3. Domestic Semiconductor Testing Equipment Market - The domestic market for semiconductor testing equipment is primarily dominated by foreign companies, with a significant opportunity for domestic manufacturers to increase their market share [40]. - Current projections indicate that the domestic localization rate for storage testing machines will only be 8% by 2025, and for SOC testing machines, it will be 9% by 2027 [44]. 4. Investment Recommendations - The report suggests focusing on domestic companies such as Changchuan Technology, Huafeng Measurement and Control, Jinhaitong, Jingzhida, and Helin Micro-Nano, which are expected to benefit from the growing demand for semiconductor testing equipment [4].

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board Semiconductor Materials and Equipment Theme Index decreased by 0.30% as of July 21, 2025, with mixed performance among constituent stocks [1] - Hanbo Semiconductor signed a counseling agreement with CITIC Securities on July 11, 2025, to officially start its A-share IPO process, focusing on high-end GPU chip solutions for AI core computing power and graphics rendering [1] - Shanxi Securities highlights the urgent need for domestic lithography machine production due to the construction boom of wafer fabs in China and increased U.S. export controls on semiconductor equipment [1] Group 2 - The Sci-Tech Innovation Board Semiconductor ETF (588170) tracks the Semiconductor Materials and Equipment Theme Index, encompassing hard-tech companies in the semiconductor equipment and materials sectors [2] - The semiconductor equipment and materials industry is a crucial area for domestic substitution, characterized by low domestic substitution rates and high potential for domestic replacement, benefiting from the expansion of semiconductor demand driven by the AI revolution [2]

Core Viewpoint - The company, Helin Micro-Nano (688661.SH), is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global brand recognition, competitiveness, and capital structure [1] Group 1: H-Share Listing Plans - The company is in discussions with intermediaries regarding the specifics of the H-share listing, which is still in the planning stage and subject to board and shareholder approval, as well as regulatory review [1][2] - The H-share listing is aimed at optimizing capital structure and expanding financing channels while maintaining the current control structure of the company [1] Group 2: Previous Fundraising Activities - Helin Micro-Nano was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 29, 2021, with an issuance of 20 million shares at a price of 17.71 yuan per share, raising a total of 354 million yuan [2] - The company raised a net amount of 312 million yuan after deducting issuance costs, which was 15.3 million yuan less than the planned amount [2] - The funds raised were allocated to various projects, including 141 million yuan for MEMS precision electronic components expansion and 110 million yuan for R&D center construction [2] Group 3: Financial Performance - In 2024, the company reported revenue of 569 million yuan, a year-on-year increase of 99.13%, while the net profit attributable to shareholders was -8.71 million yuan, an improvement from -20.94 million yuan the previous year [4] - The company also reported a net cash flow from operating activities of 14.05 million yuan, compared to -11.06 million yuan in the previous year [4]

Group 1 - The company Helin Micro-Nano (688661.SH) is advancing its "A+H" listing strategy by planning to issue H-shares and list on the Hong Kong Stock Exchange [1][3] - The primary goal of this move is to enhance the company's global development strategy, increase brand recognition, and optimize capital structure [3][6] - The company has shown significant growth in overseas revenue, projecting 1.76 billion yuan in 2024, a year-on-year increase of 157.87% [2][5] Group 2 - Helin Micro-Nano was listed on the Sci-Tech Innovation Board in March 2021, raising 354 million yuan through its IPO [2][4] - The company has experienced a recovery in overall performance, with a revenue of 2.09 billion yuan in Q1 2025, reflecting a year-on-year growth of 115.95% [2][6] - The company's gross profit margin for overseas operations stands at 31.58%, significantly higher than the domestic margin of 10.64% [5][6] Group 3 - The company has established a strong customer base, including major clients like NVIDIA, AMD, Infineon, and Broadcom, contributing to its competitive advantage [6] - The recent trend of A-share companies listing in Hong Kong has been supported by favorable policies from the China Securities Regulatory Commission [3][5] - As of 2024, the company has invested 2.59 billion yuan in key projects, achieving an investment progress of 83.14% [4]

Company Announcements - Jihua Group's existing product system does not involve brain-computer interface related fields [1] - Prit's plan to invest 1 billion yuan to build a plastic modification materials headquarters and R&D manufacturing base in South China [1][2] - Lian De Equipment won a contract worth 157 million yuan for BOE's 8.6 generation AMOLED production line project [1][2] - Jiadu Technology plans to issue shares (H-shares) overseas and list on the Hong Kong Stock Exchange [1][2] - Longdi Group intends to acquire no more than 20.1667% equity in Jujia Technology [1][4] - New Zhonggang plans to repurchase shares worth 40 million to 80 million yuan [1][4] - Xiaogoods City expects a net profit increase of 12.57% to 17.40% in the first half of the year [1][4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials through block trading [1][4] - Lihua Co., Ltd. intends to reduce its holdings by no more than 3.00% [1][4] - Zhimin Da plans to raise no more than 213 million yuan through a private placement [1][5] - Xiangtong Co. plans to issue corporate bonds not exceeding 4 billion yuan [1][5] Performance Forecasts - Hanyu Pharmaceutical expects a half-year profit of 142 million to 162 million yuan, turning a profit compared to the previous year [4] - Taotao Automotive anticipates a net profit increase of 70.34% to 97.81% in the first half of the year [4] - Weichai Heavy Machinery expects a net profit increase of 40% to 60% in the first half of the year [4] Shareholding Changes - Lihua Co., Ltd.'s actual controller Cheng Lili and his concerted actors plan to reduce their holdings by no more than 3.00% [4] - He Shi Eye Hospital's Advanced Manufacturing Fund plans to reduce its holdings by no more than 2% [4] - Haitan Ruisheng's shareholder He Lin and his concerted actors plan to reduce their holdings by no more than 2.9463% [4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials [4] Other Announcements - Zhimin Da plans to raise no more than 213 million yuan through a private placement [5] - Yuyuan Co. plans to issue corporate bonds not exceeding 40 billion yuan [5] - Jinhongshun has terminated the planning of a major asset restructuring [5]

Group 1 - Taotao Automotive expects a net profit of 310 million to 360 million yuan for the first half of 2025, representing a year-on-year increase of 70.34% to 97.81% [1] - The company specializes in the research, production, and sales of all-terrain vehicles, electric golf carts, electric scooters, electric balance bikes, electric bicycles, and their accessories [1] - China Communications Construction Company plans to repurchase shares worth between 500 million to 1 billion yuan, with a maximum repurchase price of 13.58 yuan per share [1][2] Group 2 - Annoqi's subsidiary received a government subsidy of 1.65 million yuan, accounting for 34.77% of the company's latest audited net profit [2] - Annoqi focuses on the research, production, and sales of mid-to-high-end differentiated dyes [3] - Minfeng Special Paper announced the complete shutdown of its Nanhu plant, as its Haiyan plant is now capable of handling the production capacity [4] Group 3 - Aoto Electronics received a trademark registration certificate from Saudi Arabia, covering various electronic products [5] - Landi Group plans to acquire up to 20.1667% of the shares of Jujia Technology for a total price not exceeding 121 million yuan [6][7] - Lifan Pharmaceutical's Danpi phenol raw material drug has been approved for market launch, utilizing a new process that enhances efficiency and meets market demand [8] Group 4 - Shanghai Construction received a total of 548 million yuan in government subsidies, which accounts for 22.79% of the company's latest audited net profit [8] - Wanbangde's subsidiary received ethical approval for a key clinical trial of a new drug for Alzheimer's disease [8] - Prolo Pharmaceutical's subsidiary received approval for the market launch of a new raw material drug for liver cancer treatment [9] Group 5 - Chenguang New Materials received a government subsidy of 26 million yuan, representing 62.86% of the company's latest audited net profit [10] - Sanyou Medical's subsidiary received a government subsidy of 331,000 yuan, accounting for 28.86% of the company's latest audited net profit [11] - Weichai Heavy Machinery expects a net profit of 132 million to 151 million yuan for the first half of 2025, reflecting a year-on-year increase of 40% to 60% [12] Group 6 - Guanhao Biological announced the termination of its application for a specific stock issuance [13] - China Film plans to use up to 1.5 billion yuan of idle funds for cash management [14] - Aotai Biological intends to use up to 480 million yuan of idle raised funds for cash management [15] Group 7 - Helin Micro-Nano is planning to issue overseas shares and list on the Hong Kong Stock Exchange [17] - Jinpan Technology's vice president resigned due to personal health reasons [18] - Tongyi Zhong's chairman and general manager plan to reduce their shareholdings in the company [19] Group 8 - Naipu Mining signed an overseas contract worth 18.85 million USD [21] - Zhengye Technology completed an asset sale transaction worth 178 million yuan [23] - Lianxin Equipment won a bid for a project worth 157 million yuan from BOE [24] Group 9 - Smart Control plans to apply for a comprehensive credit line of up to 260 million yuan from banks [25] - Keyuan Pharmaceutical's application for issuing shares to purchase assets has been accepted by the Shenzhen Stock Exchange [27] - Meige Intelligent's H-share listing application materials have been received by the China Securities Regulatory Commission [29] Group 10 - Siwei Tuxin's subsidiary submitted an H-share listing application [32] - Metro Design's application for issuing shares to purchase assets has been accepted by the Shenzhen Stock Exchange [32] - Aeston submitted an application for H-share listing [34] Group 11 - Jiu Ri New Materials' shareholders plan to reduce their holdings by a total of 98,900 shares [34] - Yihua Tong's shareholder plans to reduce their holdings by up to 700,000 shares [35] - Xishanghai plans to distribute a cash dividend of 0.08 yuan per share [36] Group 12 - Zhejiang Natural plans to distribute a cash dividend of 1.97 yuan for every 10 shares [37] - Kouzi Jiao plans to distribute a cash dividend of 1.30 yuan per share [38] - Huitong Group plans to distribute a cash dividend of 0.023 yuan per share [40] Group 13 - Tongyong Co. plans to reduce its holdings by up to 0.31% of the company's shares [41] - China Shenhua plans to distribute a cash dividend of 2.26 yuan for every 10 shares [43] - Huangting International's executive director resigned due to personal reasons [45] Group 14 - Jinkai New Energy plans to distribute a cash dividend of 1 yuan for every 10 shares [46] - Heimu Dan plans to distribute a cash dividend of 0.041 yuan per share [47] - Feiyada plans to acquire all or part of the controlling stake in Chang Kong Gear [48]

证券代码：688661 证券简称：和林微纳 编号：2025-025 苏州和林微纳科技股份有限公司 关于筹划公司在香港联合交易所有限公司上市的 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 为深入推进公司全球化发展战略，进一步提升公司的全球品牌知名度及竞争 力，巩固行业地位，同时更好地利用国际资本市场优势，优化资本结构，拓展多 元化融资渠道，提升公司治理水平和核心竞争力，苏州和林微纳科技股份有限公 司(以下简称"公司")正在筹划发行境外股份（H 股）并在香港联合交易所有限 公司（以下简称"香港联交所"）上市事项（以下简称"本次 H 股上市"）。公 司正与相关中介机构就本次 H 股上市的具体推进工作进行商讨，相关细节尚未 确定，本次 H 股上市不会导致公司控股股东和实际控制人发生变化。 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上海证券交易 所科创板股票上市规则》、《境内企业境外发行证券和上市管理试行办法》、《香港 联合交易所有限公司证券上市规则》等相关规定，待确定具体方案后，本次 H 股 上市工 ...

Group 1 - The company is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global brand recognition and competitiveness [1] - The company is currently discussing specific progress on the H-share listing with relevant intermediary institutions, and details are yet to be determined [1] - The H-share listing will not result in any changes to the company's controlling shareholder or actual controller [1]

一、募集资金基本情况 根据中国证券监督管理委员会《关于同意苏州和林微纳科技股份有限公司向 特定对象发行股票注册的批复》（证监许可[2022]1105 号）文件核准，本公司向 特定投资者发行人民币普通股股票 9,874,453 股，发行价为每股 70.89 元，募集 资金总额人民币 699,999,973.17 元，扣除发行费用（不含税）10,481,485.32 元后， 实际募集资金净额为人民币 689,518,487.85 元。上述募集资金已经天衡会计师事 务所（特殊普通合伙）出具的天衡验字（2022）00122《验资报告》验证。 二、募集资金投资项目情况 国泰海通证券股份有限公司 关于苏州和林微纳科技股份有限公司 使用自有资金支付募投项目所需资金 并以募集资金等额置换的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"、"保荐人"）作为苏州和 林微纳科技股份有限公司（以下简称"公司"、"和林微纳"）2021 年度向特定对象 发行股票的持续督导机构，根据《证券发行上市保荐业务管理办法》《上海证券 交易所科创板股票上市规则》《上市公司监管指引第 2 号——上市公司募集资金 管理和使用的监管要求》《上海证 ...